TY  - CONF

T1  - Abstract P2-12-01: Dose- and exposure-response relationship and biomarker correlation analysis in breast tumors from patients treated with capivasertib, an AKT inhibitor, in the STAKT randomized, placebo controlled pre-surgical study

JO  - Poster Session Abstracts

PY  - 2019/02/01

AU  - Gee J

AU  - Coleman RE

AU  - Cheung KL

AU  - Evans A

AU  - Holcombe C

AU  - Skene A

AU  - Rea D

AU  - Ahmed S

AU  - Jahan A

AU  - Horgan K

AU  - Rauchhaus P et al

ED  - 

DO  - DOI: 10.1158/1538-7445.sabcs18-p2-12-01

PB  - American Association for Cancer Research

Y2  - 2025/10/10

ER  -